InsiderTrades.com logo
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳
From Mode Mobile   |   Ad
45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.
Claim Exclusive 100% Bonus: $0.25/Share

DXR Insider Trading

Insider Ownership Percentage: 59.00%
Insider Buying (Last 12 Months): $25,787.85
Insider Selling (Last 12 Months): $0.00

Daxor Insider Trading History Chart

This chart shows the insider buying and selling history at Daxor by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Daxor Share Price & Price History

Current Price: $9.00
Price Change: ▲ Price Increase of +0.3 (3.45%)
As of 09/9/2024 01:00 AM ET

This chart shows the closing price history over time for DXR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Trump’s weapon lurks in abandoned America
From Porter & Company   |   Ad
Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…
Go here now to watch my new documentary

Daxor Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/27/2024Robert J MichelCFOBuy750$8.70$6,525.0011,300View SEC Filing Icon  
12/1/2023Michael Richard FeldschuhCEOBuy800$7.80$6,240.00162,492View SEC Filing Icon  
12/1/2023Robert J MichelCFOBuy180$7.75$1,395.0010,430View SEC Filing Icon  
11/24/2023Robert J MichelCFOBuy500$7.94$3,970.0010,250View SEC Filing Icon  
11/9/2023Michael Richard FeldschuhCEOBuy401$7.85$3,147.85160,607View SEC Filing Icon  
10/13/2023Robert J MichelCFOBuy500$9.02$4,510.007,750View SEC Filing Icon  
See Full Table
War on Elon Escalates…
From Porter & Company   |   Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.

SEC Filings (Institutional Ownership Changes) for Daxor (NASDAQ:DXR)

1.34% of Daxor stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Daxor logo
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Read More on Daxor

Today's Range

Now: $9.00
Low: $8.97
High: $9.48

50 Day Range

MA: $8.82
Low: $7.81
High: $9.70

52 Week Range

Now: $9.00
Low: $7.11
High: $10.04

Volume

10,071 shs

Average Volume

3,378 shs

Market Capitalization

$43.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Daxor?

Daxor's top insider investors include:
  1. Michael Richard Feldschuh (CEO)
  2. Robert J Michel (CFO)
Learn More about top insider investors at Daxor.
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳
From Mode Mobile   |   Ad
45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.
Claim Exclusive 100% Bonus: $0.25/Share